Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Adicet Bio Inc ACET

Healthcare Biotechnology
Adicet Bio, Inc. is a clinical stage biotechnology company. The Company is engaged in advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the... see more

Recent & Breaking News (NDAQ:ACET)

resTORbio Announces Positive Topline Results in Phase 2b Trial of RTB101

GlobeNewswire July 25, 2018

resTORbio Announces Science Translational Medicine Publication of Phase 2a Data Showing Improvement in Immune Function and Decreased Infection Rates in People Aged 65 Years and Older

GlobeNewswire July 11, 2018

resTORbio Announces Appointment of Kerry Russell, M.D., Ph.D., as Vice President of Clinical Development

GlobeNewswire June 12, 2018

resTORbio to Present at the Jefferies 2018 Global Healthcare Conference

GlobeNewswire June 1, 2018

resTORbio Reports First Quarter 2018 Financial Results

GlobeNewswire May 10, 2018

resTORbio to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

GlobeNewswire May 9, 2018

resTORbio Completes Dosing of Patients in Phase 2b Study to Reduce the Incidence of Respiratory Tract Infections in the Elderly

GlobeNewswire May 9, 2018

resTORbio to Present at the Deutsche Bank 43rd Annual Health Care Conference

GlobeNewswire May 1, 2018

resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results

GlobeNewswire March 29, 2018

resTORbio Announces Formation of Clinical Advisory Board

GlobeNewswire March 19, 2018

resTORbio to Present at the 2018 RBC Capital Markets Global Healthcare Conference

GlobeNewswire February 20, 2018

resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire January 30, 2018